MLYS INVESTOR ALERT

    101 Aufrufe 101 0 Kommentare 0 Kommentare

    Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

    Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mineralys Therapeutics, Inc. (“Mineralys” or “the Company”) (NASDAQ: MLYS). Investors who purchased Mineralys securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/MLYS.

    Investigation Details

    On August 13, 2024, Mineralys released its second quarter 2024 financial results. The Company’s earnings per share badly missed analyst consensus estimates. Following this news, Mineralys' stock dropped sharply that same day.

    What's Next?

    If you are aware of any facts relating to this investigation or purchased Mineralys securities, you can assist this investigation by visiting the firm’s site: bgandg.com/MLYS. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

    There is No Cost to You

    We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

    Why Bronstein, Gewirtz & Grossman

    Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

    Attorney advertising. Prior results do not guarantee similar outcomes.


    The Mineralys Therapeutics Stock at the time of publication of the news with a fall of -0,74 % to 12,01USD on Nasdaq stock exchange (20. September 2024, 21:43 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    MLYS INVESTOR ALERT Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm! Attorney Advertising-Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mineralys Therapeutics, Inc. (“Mineralys” or “the Company”) (NASDAQ: MLYS). Investors who purchased Mineralys securities are …